Wei Lou

6.7k total citations
111 papers, 5.2k citations indexed

About

Wei Lou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Wei Lou has authored 111 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 53 papers in Pulmonary and Respiratory Medicine and 33 papers in Oncology. Recurrent topics in Wei Lou's work include Prostate Cancer Treatment and Research (50 papers), Cytokine Signaling Pathways and Interactions (12 papers) and Cancer, Lipids, and Metabolism (11 papers). Wei Lou is often cited by papers focused on Prostate Cancer Treatment and Research (50 papers), Cytokine Signaling Pathways and Interactions (12 papers) and Cancer, Lipids, and Metabolism (11 papers). Wei Lou collaborates with scholars based in United States, China and Czechia. Wei Lou's co-authors include Allen C. Gao, Nagalakshmi Nadiminty, Christopher P. Evans, Chengfei Liu, Yezi Zhu, Soo Ok Lee, John T. Isaacs, Ramakumar Tummala, Cameron M. Armstrong and Joy C. Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Wei Lou

107 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Lou United States 45 2.7k 2.1k 1.5k 1.5k 488 111 5.2k
Adrie van Bokhoven United States 35 2.5k 0.9× 1.6k 0.7× 1.1k 0.7× 992 0.7× 312 0.6× 74 4.6k
Claudio Festuccia Italy 45 2.8k 1.0× 1.1k 0.5× 1.1k 0.7× 1.6k 1.1× 536 1.1× 164 5.3k
Allen C. Gao United States 54 4.4k 1.6× 3.5k 1.6× 2.6k 1.7× 2.7k 1.8× 761 1.6× 161 8.4k
Jeffrey E. Green United States 41 3.7k 1.4× 752 0.4× 1.8k 1.2× 2.7k 1.8× 679 1.4× 103 6.4k
Stefano Pepe Italy 45 2.6k 1.0× 1.1k 0.5× 647 0.4× 2.5k 1.7× 440 0.9× 130 5.3k
Alexander T.H. Wu Taiwan 40 2.6k 1.0× 684 0.3× 1.1k 0.7× 1.1k 0.8× 484 1.0× 170 5.1k
Deborah A. Altomare United States 37 4.0k 1.5× 1.3k 0.6× 1.0k 0.7× 1.7k 1.1× 683 1.4× 69 6.4k
F. Michael Yakes United States 15 3.4k 1.3× 1.1k 0.5× 679 0.4× 2.3k 1.5× 428 0.9× 20 5.9k
Peng Hou China 41 3.3k 1.2× 618 0.3× 1.1k 0.7× 1.3k 0.9× 429 0.9× 177 5.7k
Joseph A. Fontana United States 45 3.8k 1.4× 694 0.3× 1.0k 0.7× 1.6k 1.1× 808 1.7× 144 6.0k

Countries citing papers authored by Wei Lou

Since Specialization
Citations

This map shows the geographic impact of Wei Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lou more than expected).

Fields of papers citing papers by Wei Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lou. The network helps show where Wei Lou may publish in the future.

Co-authorship network of co-authors of Wei Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Lou. A scholar is included among the top collaborators of Wei Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Lou. Wei Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ning, Shu, Wei Lou, Pui‐Kai Li, et al.. (2025). Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate Cancer. Cancers. 17(12). 1959–1959. 1 indexed citations
3.
Ning, Shu, Wei Lou, Alan P. Lombard, et al.. (2024). PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer Cells. Cancer Research Communications. 4(11). 2976–2985.
4.
Ning, Shu, Enming Xing, Wei Lou, et al.. (2024). LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer Therapy. Cancer Research. 84(21). 3617–3628. 4 indexed citations
5.
Ning, Shu, Cameron M. Armstrong, Leandro S. D’Abronzo, et al.. (2024). IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer. iScience. 27(2). 108984–108984. 6 indexed citations
6.
Ning, Shu, Cameron M. Armstrong, Wei Lou, et al.. (2023). Therapeutic Resistance Models and Treatment Sequencing in Advanced Prostate Cancer. Cancers. 15(21). 5273–5273. 3 indexed citations
7.
Ning, Shu, Chengfei Liu, Wei Lou, et al.. (2022). Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide Treatment. Molecular Cancer Therapeutics. 21(10). 1594–1607. 16 indexed citations
8.
Lombard, Alan P., Cameron M. Armstrong, Leandro S. D’Abronzo, et al.. (2022). Olaparib-Induced Senescence Is Bypassed through G2–M Checkpoint Override in Olaparib-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 21(4). 677–685. 14 indexed citations
9.
Armstrong, Cameron M., Chengfei Liu, Liangren Liu, et al.. (2020). Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate Cancer. Clinical Cancer Research. 26(22). 6064–6074. 17 indexed citations
10.
Liu, Chengfei, Joy C. Yang, Cameron M. Armstrong, et al.. (2019). AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer. Molecular Cancer Therapeutics. 18(10). 1875–1886. 53 indexed citations
11.
Liu, Chengfei, Cameron M. Armstrong, Wei Lou, et al.. (2017). Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer. Molecular Cancer Therapeutics. 16(8). 1521–1530. 54 indexed citations
12.
Tummala, Ramakumar, Wei Lou, Allen C. Gao, & Nagalakshmi Nadiminty. (2017). Quercetin Targets hnRNPA1 to Overcome Enzalutamide Resistance in Prostate Cancer Cells. Molecular Cancer Therapeutics. 16(12). 2770–2779. 86 indexed citations
13.
Nadiminty, Nagalakshmi, Ramakumar Tummala, Chengfei Liu, et al.. (2015). NF-κB2/p52:c-Myc:hnRNPA1 Pathway Regulates Expression of Androgen Receptor Splice Variants and Enzalutamide Sensitivity in Prostate Cancer. Molecular Cancer Therapeutics. 14(8). 1884–1895. 100 indexed citations
14.
Zhu, Yezi, Chengfei Liu, Nagalakshmi Nadiminty, et al.. (2013). Inhibition of ABCB1 Expression Overcomes Acquired Docetaxel Resistance in Prostate Cancer. Molecular Cancer Therapeutics. 12(9). 1829–1836. 104 indexed citations
15.
Nadiminty, Nagalakshmi, Ramakumar Tummala, Chengfei Liu, et al.. (2013). NF-κB2/p52 Induces Resistance to Enzalutamide in Prostate Cancer: Role of Androgen Receptor and Its Variants. Molecular Cancer Therapeutics. 12(8). 1629–1637. 156 indexed citations
16.
Lou, Wei, Chengshuo Wang, Yang Wang, Demin Han, & Luo Zhang. (2011). Responses of CD4+CD25+Foxp3+ and IL‐10‐secreting type I T regulatory cells to cluster‐specific immunotherapy for allergic rhinitis in children. Pediatric Allergy and Immunology. 23(2). 141–150. 46 indexed citations
17.
Nadiminty, Nagalakshmi, Wei Lou, Meng Sun, et al.. (2010). Aberrant Activation of the Androgen Receptor by NF-κB2/p52 in Prostate Cancer Cells. Cancer Research. 70(8). 3309–3319. 91 indexed citations
18.
Nadiminty, Nagalakshmi, Wei Lou, Soo Ok Lee, et al.. (2006). Prostate-Specific Antigen Modulates Genes Involved in Bone Remodeling and Induces Osteoblast Differentiation of Human Osteosarcoma Cell Line SaOS-2. Clinical Cancer Research. 12(5). 1420–1430. 45 indexed citations
19.
Mehraein‐Ghomi, Farideh, Soo In Lee, Wei Lou, et al.. (2004). Prostate-specific antigen (PSA) regulates expression of osteoblast-associated genes and induces osteoblastic differentiation of human osteosarcoma cell line SaOS-2. Cancer Research. 64. 1034–1034. 1 indexed citations
20.
Gao, Allen C., Wei Lou, Jin‐Tang Dong, et al.. (2003). Defining regulatory elements in the human KAI1 (CD 82) metastasis suppressor gene. The Prostate. 57(4). 256–260. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adrie van Bokhoven Breakdown of academic impact, for papers by Claudio Festuccia Breakdown of academic impact, for papers by Allen C. Gao Breakdown of academic impact, for papers by Jeffrey E. Green Breakdown of academic impact, for papers by Stefano Pepe Breakdown of academic impact, for papers by Alexander T.H. Wu Breakdown of academic impact, for papers by Deborah A. Altomare Breakdown of academic impact, for papers by F. Michael Yakes Breakdown of academic impact, for papers by Peng Hou Breakdown of academic impact, for papers by Joseph A. Fontana
Rankless by CCL
2026